S Zbinden

410 total citations
7 papers, 284 citations indexed

About

S Zbinden is a scholar working on Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, S Zbinden has authored 7 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Surgery, 2 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in S Zbinden's work include interferon and immune responses (1 paper), Extracellular vesicles in disease (1 paper) and Cardiac Fibrosis and Remodeling (1 paper). S Zbinden is often cited by papers focused on interferon and immune responses (1 paper), Extracellular vesicles in disease (1 paper) and Cardiac Fibrosis and Remodeling (1 paper). S Zbinden collaborates with scholars based in Switzerland, Italy and United Kingdom. S Zbinden's co-authors include Hassan Izzedine, Bernard Escudier, Caroline Robert, Tim Eisen, L Pyle, Peter F.A. Mulders, Cora N. Sternberg, Luigi Mariani, Erik Vassella and Mario P. Tschan and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cardiovascular Research and Heart.

In The Last Decade

S Zbinden

6 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Zbinden Switzerland 4 175 104 98 64 33 7 284
Dawn Q. Chong Singapore 10 141 0.8× 149 1.4× 51 0.5× 115 1.8× 49 1.5× 21 471
Magdalena Benetkiewicz France 14 139 0.8× 110 1.1× 104 1.1× 159 2.5× 68 2.1× 18 413
Salma Alam United Kingdom 10 91 0.5× 86 0.8× 160 1.6× 143 2.2× 53 1.6× 14 332
Chirag Amin United States 6 195 1.1× 123 1.2× 210 2.1× 42 0.7× 41 1.2× 17 309
Andrew Wiechert United States 9 149 0.9× 77 0.7× 154 1.6× 138 2.2× 66 2.0× 13 389
Hui-Lan Rao China 11 264 1.5× 142 1.4× 61 0.6× 105 1.6× 33 1.0× 13 482
Jichong Xu China 13 181 1.0× 157 1.5× 101 1.0× 39 0.6× 39 1.2× 24 413
M. Maasberg Germany 8 139 0.8× 61 0.6× 52 0.5× 104 1.6× 34 1.0× 15 330
Emma V. Morris United Kingdom 10 144 0.8× 120 1.2× 40 0.4× 133 2.1× 23 0.7× 14 374
Anna Berand Germany 8 181 1.0× 118 1.1× 75 0.8× 153 2.4× 21 0.6× 15 331

Countries citing papers authored by S Zbinden

Since Specialization
Citations

This map shows the geographic impact of S Zbinden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Zbinden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Zbinden more than expected).

Fields of papers citing papers by S Zbinden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Zbinden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Zbinden. The network helps show where S Zbinden may publish in the future.

Co-authorship network of co-authors of S Zbinden

This figure shows the co-authorship network connecting the top 25 collaborators of S Zbinden. A scholar is included among the top collaborators of S Zbinden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Zbinden. S Zbinden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
2.
Haemmig, Stefan, Ulrich Baumgartner, S Zbinden, et al.. (2014). miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas. Cell Death and Disease. 5(6). e1279–e1279. 69 indexed citations
3.
Eisen, Tim, Cora N. Sternberg, Caroline Robert, et al.. (2012). Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies. JNCI Journal of the National Cancer Institute. 104(2). 93–113. 156 indexed citations
4.
Zbinden, S, et al.. (2010). Effets indésirables cardiovasculaires du traitement médicamenteux monderne du cancer. Forum Médical Suisse ‒ Swiss Medical Forum. 10(8).
5.
Meier, Pascal, Janine Antonov, Rainer Zbinden, et al.. (2008). Non-invasive gene-expression-based detection of well-developed collateral function in individuals with and without coronary artery disease. Heart. 95(11). 900–908. 22 indexed citations
6.
Kinnaird, Tim, Eugenio Stabile, S Zbinden, Mary Susan Burnett, & Stephen E. Epstein. (2008). Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions. Cardiovascular Research. 78(2). 257–264. 34 indexed citations
7.
Zbinden, S, et al.. (2008). Aging impairs both collateral development and angiogenesis in mice. Cardiovascular revascularization medicine. 9(3). 213–214. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026